Correction: Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Investigating Stem-like CD4 T Cells in Tumors: A New Perspective on Antitumor Immunity

  • By

  • Jiaxiang Xu

  • Yunchao Yang

  • Jun Zhang

  • Yue Zhang

  • September 14, 2026

Share

  • 1

    The article discusses stem-like CD4 T cells in tumors and their role in antitumor immunity.

  • 2

    A correction was issued regarding the authors' institutional affiliation.

  • 3

    The correct affiliation is Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

  • 4

    The erroneous designation was related to the Emergency Surgery department.

  • 5

    The original version of the article has been updated to reflect these corrections.

Original Source(s)

Correction: Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity

  • by Jiaxiang Xu, Yunchao Yang, Jun Zhang, Yue Zhang

  • September 14, 2026

Related Content

Case Report: Treatment of an unresectable mucoepidermoid carcinoma with osimertinib

Correction: Case Report: Complete response and prolonged survival to alectinib in a NSCLC patient with metastases harboring a rare WDR43::ALK structural deletion

The impact of prevalent primary cancers in melanoma patients on survival